Cristina Teragni

Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation

Cristina Sottani, Paola Rinaldi, Emanuela Leoni et al. · Rapid Communications in Mass Spectrometry · 2008 · 97 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)

Erica Quaquarini, Giuseppe Saltalamacchia, Daniele Presti et al. · Cancers · 2020 · 52 citations · Full text

Medicine, Infectious Disease Control, Oncology +17

Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

Guido Poggi, Pietro Quaretti, Claudio Minoia et al. · PubMed · 2009 · 50 citations

Pharmacy, Oncology, Pharmacokinetics +16

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Raffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò et al. · Drug Design Development and Therapy · 2015 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17